|
|
|
|
|
|
|
|
open access (req's registration/free)
Table of Contents
Editorial(s)
Original Canadian cancer costing research for cancer control sustainability, quality, and value | PDF HTML |
H. Bryant | S5 |
Importance of cost estimates and cost studies | PDF HTML |
N. Mittmann, C. de Oliveira | S6 |
Original Article(s)
Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada | PDF HTML |
P.A. Tang, A.E. Hay, C.J. O’Callaghan, N. Mittmann, C.R. Chambers, J.L. Pater, N.B. Leighl | S7-S13 |
Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis | PDF HTML |
I. Cromwell, Z. Ferreira, L. Smith, K. van der Hoek, G. Ogilvie, A. Coldman, S.J. Peacock | S14-S22 |
Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation | PDF HTML |
N.J. Look Hong, G.M. Clarke, M.J. Yaffe, C.M.B. Holloway | S23-S31 |
Population-based trends in systemic therapy use and cost for cancer patients in the last year of life | PDF HTML |
R.E. Pataky, W.Y. Cheung, C. de Oliveira, K.E. Bremner, K.K.W. Chan, J.S. Hoch, M.D. Krahn, S.J. Peacock | S32-S41 |
Temporal association between home nursing and hospital costs at end of life in three provinces | PDF HTML |
H. Seow, R. Pataky, B. Lawson,
E.M. O'Leary, R. Sutradhar, K.
Fassbender, K. McGrail, L. Barbera,
F. Burge, S.J. Peacock, J.S. Hoch (Compared with lung cancer, sites associated with higher relative hospital costs were gynecologic, hematologic, other gastrointestinal, and other genitourinary cancers.) |
S42-S51 |
Cost implications of unwarranted imaging for distant metastasis in women with early-stage breast cancer in Ontario | PDF HTML |
K. Thavorn, Z. Wang, D. Fergusson, S. van Katwyk, A. Arnaout, M. Clemons | S52-S55 |
Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada | PDF HTML |
C. Popadiuk, C.L. Gauvreau, M. Bhavsar, C. Nadeau, K. Asakawa, W.M. Flanagam, M.C. Wolfson, A.J. Coldman, S. Memon, N. Fitzgerald, J. Lacombe, A.B. Miller | S56-S63 |
Cost trajectories for cancer patients | PDF HTML |
W.P Wodchis, E. Arthurs, A.I.
Khan, S. Gandhi, M. MacKinnon, J.
Sussman (Team-based payments for family health teams and physician pay-for-performance bonuses were not ascribed to individual patients and thus were not included in the analysis.) | S64-S75 |
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.